Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1985 Oct 19;291(6502):1088-91.
doi: 10.1136/bmj.291.6502.1088.

Thirty-four year follow up of patients with breast cancer in clinical trial of postoperative radiotherapy

Clinical Trial

Thirty-four year follow up of patients with breast cancer in clinical trial of postoperative radiotherapy

M K Palmer et al. Br Med J (Clin Res Ed). .

Abstract

An extended follow up to a maximum of 34 years was carried out on a series of 1461 patients who had been entered into a randomised clinical trial comparing immediate postoperative radiotherapy (treated group) with an optional delayed radiotherapy policy (watched group) after Halsted radical mastectomy for operable breast cancer. Long term survival was compared separately in patients with negative and positive axillary nodes and in two periods when different techniques of radiotherapy were used. No significant differences were noted in survival overall or in any subgroup. In patients with negative axillary nodes treated in the earlier period when the "quadrate" radiotherapy technique was used, however, the difference in survival was of borderline significance (p = 0.052), to the benefit of the watched group. Because of the large numbers of patients entered and the long follow up any possible harmful or beneficial effect of immediate postoperative radiotherapy would have been apparent in the results of this trial. The absence of any such effect implies that postoperative radiotherapy given to prevent or delay local recurrence of breast cancer is unlikely to be associated with a detectable effect on survival.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 1974 Nov 30;2(7892):1285-6 - PubMed
    1. Br J Cancer. 1977 Jan;35(1):1-39 - PubMed
    1. World J Surg. 1977 May;1(3):284-6 - PubMed
    1. Br Med J. 1979 Nov 17;2(6200):1247-51 - PubMed
    1. Lancet. 1984 May 19;1(8386):1118 - PubMed

Publication types

LinkOut - more resources